People who take popular weight loss drugs like Ozempic can have serious side effects and new research says stopping them can also cause problems. Now that millions of people have successfully lost weight using them,

Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, rates of bariatric surgeries dropped by 25%, while prescriptions for weight-loss drugs more than doubled.

Medically reviewed by Danielle Weiss, MD After losing extra pounds on Ozempic (semaglutide), some are finding themselves dealing with an unexpected issue, what's become known as "Ozempic breasts." This possible side effect of glucagon-like peptide 1 (GLP-1) agonist medication users like Ozempic,

Weight loss and diabetes drugs Ozempic, Wegovy, Mounjaro and Zepbound are seen as game-changers for obesity and weight management but for many people, there are still questions around side effects, accessibility and results.

A recent study found semaglutide – the drug known as Ozempic – can improve knee pain in people with obesity and osteoarthritis.

"I'm using [Ozempic] off-label for a whole host of conditions — and have been for years," Dr. Caroline Messer, an endocrinologist at Northwell Lenox Hill Hospital, told The Post.

The weight-loss drug Ozempic can help reduce stroke patients' risk of a heart attack or death, a new study says.

The United Kingdom will study whether the use of weight loss drugs could get people back to work. UK Health Minister Wes Streeting announced last month that US drug manufacturer Eli Lilly will begin a five-year trial in Greater Manchester to test if the company’s weight loss drug could curb the UK’s unemployment crisis.